| Medical and Health Sciences | 2021-2025 | 263 | US 93 | 99.95 |
| Economics and Finance | 2021-2025 | 721 | US 198 | 97.15 |
| Surgery | Lifetime | 245 | US 139 | 99.79 |
| Oncology | Lifetime | 201 | US 106 | 99.68 |
| Hepatology | Lifetime | 83 | US 38 | 99.43 |
| Pulmonary and Respiratory Medicine | Lifetime | 761 | US 397 | 98.85 |
| Surgery | 2021-2025 | 30 | US 12 | 99.83 |
| Oncology | 2021-2025 | 63 | US 24 | 99.67 |
| General Health Professions | 2021-2025 | 127 | US 51 | 99.08 |
| Hepatology | 2021-2025 | 28 | US 10 | 99.25 |
| Epidemiology | 2021-2025 | 213 | US 72 | 98.45 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 201 | US 66 | 98.51 |
| Public, Environmental and Occupational Health | 2021-2025 | 367 | US 136 | 96.79 |
| Econometrics and Quantitative Economics | 2021-2025 | 510 | US 115 | 97.13 |
| Cancer Research | 2021-2025 | 104 | US 41 | 95.14 |
| Health | 2021-2025 | 266 | US 106 | 92.41 |
| Emergency Medical Services | 2021-2025 | 121 | US 32 | 86.93 |
| Gender Studies | 2021-2025 | 292 | US 135 | 86.98 |
| Geriatrics and Gerontology | 2021-2025 | 144 | US 31 | 84.02 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 871 | US 385 | 81.97 |
| Pathology and Forensic Medicine | 2021-2025 | 525 | US 167 | 72.22 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 20 | US 15 | 99.84 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 28 | US 14 | 99.84 |
| Gallbladder and Bile Duct Disorders | Lifetime | 28 | US 16 | 99.79 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 50 | US 32 | 99.79 |
| Neuroendocrine Tumor Research Advances | Lifetime | 136 | US 67 | 99.35 |
| Colorectal Cancer Treatments and Studies | Lifetime | 137 | US 70 | 99.51 |
| Gastric Cancer Management and Outcomes | Lifetime | 310 | US 116 | 99.25 |
| Gastrointestinal Tumor Research and Treatment | Lifetime | 160 | US 46 | 98.89 |
| Liver Disease Diagnosis and Treatment | Lifetime | 925 | US 289 | 98.88 |
| Pediatric Hepatobiliary Diseases and Treatments | Lifetime | 245 | US 91 | 98.46 |
| Pancreatitis Pathology and Treatment | Lifetime | 340 | US 149 | 98.34 |
| Palliative Care and End-of-Life Issues | Lifetime | 435 | US 204 | 97.96 |
| Economic and Financial Impacts of Cancer | Lifetime | 201 | US 135 | 97.49 |
| COVID-19 and healthcare impacts | Lifetime | 533 | US 194 | 94.33 |
| Cancer, Lipids, and Metabolism | Lifetime | 845 | US 387 | 97.08 |
| Metastasis and carcinoma case studies | Lifetime | 616 | US 91 | 96.01 |
| Viral-associated cancers and disorders | Lifetime | 777 | US 341 | 96.34 |
| Patient-Provider Communication in Healthcare | Lifetime | 464 | US 217 | 95.85 |
| Diversity and Career in Medicine | Lifetime | 539 | US 399 | 93.48 |
| Patient Satisfaction in Healthcare | Lifetime | 777 | US 456 | 93.26 |
| Global Health Workforce Issues | Lifetime | 831 | US 315 | 92.33 |
| Advances in Oncology and Radiotherapy | Lifetime | 635 | US 308 | 90.54 |
| Gallbladder and Bile Duct Disorders | 2021-2025 | 4 | US 1 | 99.75 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 10 | US 4 | 99.76 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 9 | US 3 | 99.75 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 15 | US 6 | 99.71 |
| Gastric Cancer Management and Outcomes | 2021-2025 | 106 | US 22 | 98.85 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 46 | US 17 | 98.67 |
| Colorectal Cancer Screening and Detection | 2021-2025 | 67 | US 24 | 98.25 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 240 | US 65 | 98.71 |
| Neuroendocrine Tumor Research Advances | 2021-2025 | 75 | US 23 | 97.67 |
| Cancer Genomics and Diagnostics | 2021-2025 | 379 | US 174 | 97.39 |
| Pediatric Hepatobiliary Diseases and Treatments | 2021-2025 | 68 | US 10 | 96.81 |
| Global Cancer Incidence and Screening | 2021-2025 | 127 | US 51 | 97.20 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 81 | US 47 | 96.78 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 175 | US 63 | 97.71 |
| Palliative Care and End-of-Life Issues | 2021-2025 | 197 | US 80 | 96.61 |
| Viral-associated cancers and disorders | 2021-2025 | 80 | US 48 | 96.16 |
| Hepatitis B Virus Studies | 2021-2025 | 225 | US 38 | 95.94 |
| Cardiac, Anesthesia and Surgical Outcomes | 2021-2025 | 653 | US 232 | 94.72 |
| Cancer Mechanisms and Therapy | 2021-2025 | 105 | US 19 | 92.97 |
| Pancreatitis Pathology and Treatment | 2021-2025 | 310 | US 73 | 93.91 |
| Primary Care and Health Outcomes | 2021-2025 | 178 | US 103 | 93.26 |
| Cancer survivorship and care | 2021-2025 | 355 | US 134 | 93.49 |
| Colorectal Cancer Surgical Treatments | 2021-2025 | 422 | US 64 | 93.77 |
| Global Health Workforce Issues | 2021-2025 | 139 | US 48 | 92.30 |
| COVID-19 and healthcare impacts | 2021-2025 | 899 | US 307 | 89.31 |
| Peptidase Inhibition and Analysis | 2021-2025 | 456 | US 120 | 91.87 |
| Esophageal Cancer Research and Treatment | 2021-2025 | 463 | US 73 | 92.55 |
| Food Security and Health in Diverse Populations | 2021-2025 | 353 | US 204 | 91.01 |
| Renal cell carcinoma treatment | 2021-2025 | 749 | US 249 | 90.55 |
| Childhood Cancer Survivors' Quality of Life | 2021-2025 | 877 | US 401 | 88.99 |
| Neuroblastoma Research and Treatments | 2021-2025 | 496 | US 185 | 88.45 |
| Organ Transplantation Techniques and Outcomes | 2021-2025 | 802 | US 316 | 90.17 |
| Inflammatory Biomarkers in Disease Prognosis | 2021-2025 | 476 | US 36 | 81.36 |
| Metastasis and carcinoma case studies | 2021-2025 | 490 | US 35 | 84.58 |
| Surgical Simulation and Training | 2021-2025 | 592 | US 176 | 84.86 |
| Liver physiology and pathology | 2021-2025 | 320 | US 48 | 81.67 |
| Healthcare Policy and Management | 2021-2025 | 735 | US 526 | 83.88 |
| Healthcare cost, quality, practices | 2021-2025 | 433 | US 182 | 81.88 |
| Diversity and Career in Medicine | 2021-2025 | 784 | US 623 | 82.44 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 498 | US 178 | 76.42 |
| Enhanced Recovery After Surgery | 2021-2025 | 509 | US 105 | 75.62 |
| Clinical practice guidelines implementation | 2021-2025 | 627 | US 119 | 72.63 |
| Hospital Admissions and Outcomes | 2021-2025 | 179 | US 127 | 71.71 |
| Grief, Bereavement, and Mental Health | 2021-2025 | 903 | US 210 | 71.31 |
| Religion, Spirituality, and Psychology | 2021-2025 | 540 | US 214 | 70.60 |
| Pain Management and Opioid Use | 2021-2025 | 880 | US 446 | 69.79 |
| Advances in Oncology and Radiotherapy | 2021-2025 | 912 | US 412 | 68.96 |
| Fibroblast Growth Factor Research | 2021-2025 | 770 | US 219 | 60.91 |